3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
17
CNS
7
Gastrointestinal
6
Lymphoid
5
Genitourinary
5
Other
2
Head & Neck
2
Gynecologic
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Dermatologic
1
Classical hematology
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
140
Myelodysplastic Syndromes
123
Myeloproliferative Disorders
103
Leukemia, Myeloid, Acute
99
Leukemia
67
Precursor Cell Lymphoblastic Leukemia-Lymphoma
53
Multiple Myeloma
52
Lymphoma
49
Primary Myelofibrosis
43
Polycythemia Vera
43
Leukemia, Lymphocytic, Chronic, B-Cell
40
Lymphoma, Non-Hodgkin
39
Hodgkin Disease
35
Leukemia, Myelomonocytic, Chronic
31
Thrombocythemia, Essential
30
Leukemia, Myeloid, Chronic-Phase
30
Hematologic Neoplasms
29
Neoplasms
27
Lymphoma, Follicular
27
Mastocytosis
26
Myelodysplastic-Myeloproliferative Diseases
24
Lymphoma, Large B-Cell, Diffuse
23
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
23
Leukemia, Myeloid, Accelerated Phase
23
Blast Crisis
23
Neoplasms, Plasma Cell
22
Congenital Abnormalities
22
Lymphoma, Mantle-Cell
21
Lymphoma, B-Cell, Marginal Zone
21
Leukemia, Hairy Cell
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Cognitive Dysfunction
×
Myeloid
×
Clear all
NCT02767388
2023-09-29
Chemobrain
University of Nebraska
Completed
45 enrolled
10 charts